Latest Italy News

ADX Energy reported a 24% drop in production due to mechanical issues but is advancing well workovers and new drilling, supported by a $3.5 million capital raise and plans for a dual listing in Oslo.

Prescient Therapeutics has secured a key regulatory milestone with the EMA granting Orphan Drug Designation for PTX-100 to treat cutaneous T-cell lymphoma, while expanding its Phase 2a clinical trial across multiple continents.

Fluence Corporation Limited has reported a robust FY 2025 with a 52.3% revenue increase and record new orders, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams.

Fluence Corporation Limited reported a positive net operating cash flow of US$3.824 million for the December 2025 quarter, ending with a strong cash position of US$16.64 million. The company’s disciplined spending and financing activities underpin its stable liquidity outlook.

Po Valley Energy Limited reported steady gas production and strong cashflows from its Podere Maiar-1 facility during the December 2025 quarter, while completing a major 3D geophysical survey to support future development.

Memphasys Limited has achieved its first material revenues following CE Mark approval for its Felix™ System, activating multi-year contracts across Europe, the Middle East, and Asia. The company is now transitioning from regulatory preparation to global commercial rollout with a focus on recurring revenues.

Memphasys Limited has extended the repayment terms of its convertible notes with major shareholder Peters Investments to mid-2026, reinforcing financial flexibility amid ongoing commercial progress.

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.

Altamin Limited has completed a $1.003 million placement, bolstering its financial position to progress key projects in Italy amid ongoing permitting and partnership efforts.

Memphasys has inked a five-year supply agreement with Italy’s Centro Fertilita Assistita, marking its first major European contract and setting the stage for broader adoption of its Felix™ sperm isolation system.

BetMakers Technology Group has secured a multi-year deal with Stake.com to provide its comprehensive RaceOdds+ wagering platform, supporting Stake’s ambitious global horse racing growth plans.

Prescient Therapeutics has secured European authorization to initiate a Phase 2a clinical trial of its novel cancer drug PTX-100 for relapsed/refractory Cutaneous T-cell Lymphoma, enabling trial site activation in Italy.